Publication
15615
page-template-default,page,page-id-15615,bridge-core-1.0.4,ajax_fade,page_not_loaded,,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.0.9,qode-theme-bridge,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-5.7,vc_responsive
 

Publication

By admin / November 10, 2022

First-in-Human Study to Evaluate Safety, Tolerabil...

Introduction: AOD01 is a novel, fully human immunoglobulin (Ig) G1 neutralizing monoclonal antibody that was developed as a therapeutic against severe...

Read More
By admin / October 10, 2021

Neem (Azadirachta Indica A. Juss) Capsules for Pro...

Context: SARS-CoV-2 is a global public-health concern. Interventions to prevent infection are urgently needed. The anti-inflammatory and antiviral effects of neem...

Read More
By admin / August 20, 2020

Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3...

Tenalisib (RP6530), a dual phosphoinositide 3-kinase δ/γ inhibitor was evaluated in a phase I/Ib study for maximum tolerated dose (MTD),...

Read More
By admin / September 16, 2019

Efficacy of an Ayurvedic Formulation for Mild-to-m...

Current treatment options offer only symptomatic pain relief for patients with osteoarthritis (OA). Thus, a need exists for effective treatment...

Read More
Publication
By admin / June 7, 2019

A pandemic influenza vaccine in India: from strain...

In the event of a highly pathogenic influenza pandemic, the Indian subcontinent would need 1.2 billion doses of vaccine to...

Read More
Publication
By admin / June 7, 2019

Diphtheria, Tetanus, and Pertussis Immunity in Ind...

Rise of diphtheria cases in adults is a cause of concern worldwide. Pertussis is also now affecting adults. We assessed...

Read More
1 2